Subject(s)

COVID-19 Vaccines/adverse effects , COVID-19/prevention & control , Drug Eruptions/diagnosis , Facial Dermatoses/diagnosis , Neutrophils/immunology , 2019-nCoV Vaccine mRNA-1273 , Aged, 80 and over , Anti-Bacterial Agents/administration & dosage , COVID-19/immunology , COVID-19/virology , Dermatologic Agents/administration & dosage , Diagnosis, Differential , Drug Eruptions/drug therapy , Drug Eruptions/immunology , Drug Eruptions/pathology , Drug Therapy, Combination , Facial Dermatoses/drug therapy , Facial Dermatoses/immunology , Facial Dermatoses/pathology , Humans , Male , Middle Aged , Rosacea/diagnosis , SARS-CoV-2/genetics , SARS-CoV-2/immunology , Skin/immunology , Skin/pathology , Treatment Outcome

Subject(s)

Antimalarials/adverse effects , COVID-19 Drug Treatment , Drug Eruptions/etiology , Hydroxychloroquine/adverse effects , Adult , Antimalarials/therapeutic use , Drug Eruptions/pathology , Female , Humans , Hydroxychloroquine/therapeutic use